UK markets closed

Medtronic plc (MDT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
123.23-1.98 (-1.58%)
At close: 4:00PM EDT
123.23 0.00 (0.00%)
After hours: 05:29PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5165.79B
Enterprise value 3183.95B
Trailing P/E 46.33
Forward P/E 119.59
PEG ratio (5-yr expected) 12.02
Price/sales (ttm)5.50
Price/book (mrq)3.22
Enterprise value/revenue 36.11
Enterprise value/EBITDA 723.96

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 333.33%
S&P500 52-week change 336.29%
52-week high 3132.30
52-week low 387.68
50-day moving average 3125.88
200-day moving average 3119.99

Share statistics

Avg vol (3-month) 34.74M
Avg vol (10-day) 34.54M
Shares outstanding 51.35B
Implied shares outstanding 6N/A
Float 1.34B
% held by insiders 10.08%
% held by institutions 183.72%
Shares short (27 May 2021) 49.3M
Short ratio (27 May 2021) 42.07
Short % of float (27 May 2021) 40.69%
Short % of shares outstanding (27 May 2021) 40.69%
Shares short (prior month 29 Apr 2021) 410.71M

Dividends & splits

Forward annual dividend rate 42.52
Forward annual dividend yield 42.02%
Trailing annual dividend rate 32.32
Trailing annual dividend yield 31.85%
5-year average dividend yield 42.08
Payout ratio 487.22%
Dividend date 315 Jul 2021
Ex-dividend date 423 Jun 2021
Last split factor 22:1
Last split date 326 Sept 1999

Financial highlights

Fiscal year

Fiscal year ends 29 Apr 2021
Most-recent quarter (mrq)29 Apr 2021


Profit margin 11.97%
Operating margin (ttm)16.52%

Management effectiveness

Return on assets (ttm)3.38%
Return on equity (ttm)7.07%

Income statement

Revenue (ttm)30.12B
Revenue per share (ttm)22.39
Quarterly revenue growth (yoy)36.50%
Gross profit (ttm)19.78B
Net income avi to common (ttm)3.61B
Diluted EPS (ttm)2.66
Quarterly earnings growth (yoy)66.80%

Balance sheet

Total cash (mrq)10.82B
Total cash per share (mrq)8.04
Total debt (mrq)26.39B
Total debt/equity (mrq)51.14
Current ratio (mrq)2.65
Book value per share (mrq)38.22

Cash flow statement

Operating cash flow (ttm)6.24B
Levered free cash flow (ttm)9.62B